Bottle of Lies
The Inside Story of the Generic Drug Boom
Failed to add items
Add to cart failed.
Add to wishlist failed.
Remove from wishlist failed.
Follow podcast failed
Unfollow podcast failed
New to Audible Prime Member exclusive: 2 credits with free trial
Bottle of Lies
Buy Now for ₹1,688.00
No valid payment method on file.
We are sorry. We are not allowed to sell this product with the selected payment method
-
Narrated by:
-
Katherine Eban
-
Written by:
-
Katherine Eban
About this listen
From an award-winning Fortune reporter, an explosive narrative investigation of the generic drug boom that reveals the life-threatening dangers posed by globalization - The Jungle for pharmaceuticals.
The widespread use of generic drugs has been hailed as one of the most important public-health developments of the 20th century. Today, almost 90 percent of our pharmaceutical market is comprised of generics, the majority of which are manufactured overseas. We have been reassured by our pharmacists, our doctors, and our regulators that the generic and brand-name drugs are identical, generics just cheaper. But is this really true?
Katherine Eban’s Bottle of Lies exposes the widespread deceit behind generic-drug manufacturing - creating terrifying risks for global health. Drawing on exclusive accounts from whistle-blowers, inspectors, and regulators, as well as thousands of pages of confidential internal FDA documents, Eban reveals an industry where fraud is rampant, companies falsify data, and executives circumvent almost every principle of safe manufacturing to minimize cost and maximize profit. Meanwhile, patients unwittingly consume adulterated medicine with unpredictable and even life-threatening effects.
The story of generic drugs is truly global: It connects middle America to sub-Saharan Africa, China, India, and Brazil and encompasses every market banking on the promise of a low-cost cure. Given that tens of millions of patients take drugs of dubious quality approved with fake data, the generics industry is the ultimate litmus test of globalization: What is the risk of moving drug manufacturing offshore, and is it worth the savings?
An investigation with international sweep, exotic settings, molecular mayhem, and big money at its core, Bottle of Lies reveals how the world’s greatest public-health innovation has become one of its most astonishing swindles.
©2019 Katherine Eban (P)2019 HarperCollins PublishersWhat listeners say about Bottle of Lies
Average Customer RatingsReviews - Please select the tabs below to change the source of reviews.
-
Overall5 out of 5 stars
-
Performance5 out of 5 stars
-
Story5 out of 5 stars
- ARR
- 05-12-20
Brilliant
This is incredibly well researched, written, and read. It should be made into a movie.
Something went wrong. Please try again in a few minutes.
You voted on this review!
You reported this review!
1 person found this helpful
-
Overall5 out of 5 stars
-
Performance4 out of 5 stars
-
Story4 out of 5 stars
- Raghav
- 07-06-22
incisive
in depth reporting of the greatest fraud related to human health, but biased towards USFDA being the only strictest regulator in the world
Something went wrong. Please try again in a few minutes.
You voted on this review!
You reported this review!
-
Overall5 out of 5 stars
-
Performance5 out of 5 stars
-
Story5 out of 5 stars
- Innderr
- 06-03-22
Very interesting!!
Very well written on the underlying bad pharmacy practices done by few which impacts the majority of the world.
Something went wrong. Please try again in a few minutes.
You voted on this review!
You reported this review!
-
Overall5 out of 5 stars
-
Performance5 out of 5 stars
-
Story5 out of 5 stars
- Vachan Hukkeri
- 18-03-21
if you are ever planning to take any medicine
An absolutely brilliant account of the fraud being conducted by the generic drug industry. It pains me personally more since I am an Indian, a doctor and also someone who at one time used to vouch for generic drugs. If you sometimes feel, why the medicines you take don't work... Or cause you more harm.... Read this book.👍👍
Something went wrong. Please try again in a few minutes.
You voted on this review!
You reported this review!
-
Overall5 out of 5 stars
-
Performance5 out of 5 stars
-
Story5 out of 5 stars
- Karun Bir Singh Sandha
- 26-08-20
Very Good Research Work
It's very good piece of work but seems to be highly biased against Generic players in general. USFDA is shown as slow and bureaucratic organisation and all Asian and specifically Indian companies are being shown in bad light. All things equal author should appreciate the fact that getting lower quality is much more important than not getting any medicine (on account of high costs of branded players specially in case of African countries).
Something went wrong. Please try again in a few minutes.
You voted on this review!
You reported this review!
2 people found this helpful
-
Overall5 out of 5 stars
-
Performance5 out of 5 stars
-
Story5 out of 5 stars
- Goldy
- 14-08-20
Nice book
Nice book with good explanation of facts. .. it reveals the dark site of pharmaceutical industries, special generic medicines.
Something went wrong. Please try again in a few minutes.
You voted on this review!
You reported this review!
-
Overall5 out of 5 stars
-
Performance4 out of 5 stars
-
Story5 out of 5 stars
- Manas Phadke
- 07-02-24
Very well written and narrated
Katherine's pronunciation of Indian names and places is quite off but its a minor wrinkle in what is an amazing book. After completing this book, when taking any pills, I've invariably started checking where it was manufactured and by whom.
Something went wrong. Please try again in a few minutes.
You voted on this review!
You reported this review!
-
Overall5 out of 5 stars
-
Performance5 out of 5 stars
-
Story5 out of 5 stars
- Namrata
- 20-04-21
Shocking and definitely should be read
Bottle of Lies, a book about the quality problems plaguing generic drugs. In May 2013, Ranbaxy Laboratories admitted in an American court to selling adulterated drugs. It begins with Dinesh Thakur, the whistle-blower who exposed Ranbaxy’s misdeeds. In 2003, Thakur left his job at Bristol Myers Squibb’s New Jersey office to join the Gurgaon office of Ranbaxy — then a rising star of the Indian generics industry. There, he encountered a shocking web of chicanery. Wockhardt’s manufacturing plants too are now blocked from exporting drugs to the U.S.
China and Ghana is no better as far as quality control is concerned.
Quite shocking and worth a read.
Something went wrong. Please try again in a few minutes.
You voted on this review!
You reported this review!
1 person found this helpful
-
Overall5 out of 5 stars
-
Performance4 out of 5 stars
-
Story4 out of 5 stars
- VVR
- 16-04-23
Indeed a Revelation
The contents of this book - the audio version - was an eye opener to the world of medicines. The entire journey of listening to this book was riveting. Well crafted story board spiced with the cruel and callous underbelly of the pharma industry. Well done.
Something went wrong. Please try again in a few minutes.
You voted on this review!
You reported this review!
-
Overall1 out of 5 stars
-
Performance1 out of 5 stars
-
Story1 out of 5 stars
- Prashant singh
- 14-05-22
dramatic
there is a lot more drama than substance. feel like fiction writing. it's off putting due to that drama.
Something went wrong. Please try again in a few minutes.
You voted on this review!
You reported this review!